Many triple-negative breast cancers (TNBCs) express high levels of AhR, and in patients with ER+ or ER-/PR- breast cancers, higher expression levels of AhR correlated with improved relapse-free survival relative to ER- and PR-negative cancers with a low expression of AhR [9]. Here, ESR1 is linked to breast carcinoma.